SCOTT D SANDELL Insider Trading Transactions
Get free email notifications about insider trading for SCOTT D SANDELL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of SCOTT D SANDELL. SCOTT D SANDELL is 10% Owner in ARADIGM CORP ($ARDM) and 10% Owner in ARCA biopharma, Inc. ($ABIO) and 10% Owner in INTERLEUKIN GENETICS INC ($ILIU) and 10% Owner in Marker Therapeutics, Inc. ($MRKR) and 10% Owner in ZTI MERGER SUBSIDIARY III INC ($ZHNE) and 10% Owner in Paratek Pharmaceuticals, Inc. ($PRTK) and in MYOGEN INC ($MYOG) and 10% Owner in MYOGEN INC ($MYOG) and in PHARMION CORP ($PHRM) and 10% Owner in PHARMION CORP ($PHRM) and 10% Owner in CATALYST BIOSCIENCES, INC. ($CBIO) and 10% Owner in Vitae Pharmaceuticals, Inc ($VTAE) and 10% Owner in GLYCOMIMETICS INC ($GLYC) and 10% Owner in INHIBITEX, INC. ($INHX) and 10% Owner in VONAGE HOLDINGS CORP ($VG) and 10% Owner in Achaogen Inc ($AKAO) and 10% Owner in Liquidia Technologies Inc ($LQDA) and 10% Owner in AVEO PHARMACEUTICALS INC ($AVEO) and 10% Owner in INTERCELL USA, INC. ($IOMI) and 10% Owner in INNERWORKINGS INC ($INWK) and 10% Owner in SUPERNUS PHARMACEUTICALS INC ($SUPN) and 10% Owner in MULESOFT, INC ($MULE) and Director in Data Domain, Inc. ($DDUP) and 10% Owner in HYPERION THERAPEUTICS INC ($HPTX) and 10% Owner in Tracon Pharmaceuticals, Inc. ($TCON) and 10% Owner in Cascadian Therapeutics, Inc. ($CASC) and 10% Owner in Care.com Inc ($CRCM) and 10% Owner in ARDELYX, INC. ($ARDX) and 10% Owner in APPIAN CORP ($APPN) and 10% Owner in Mersana Therapeutics, Inc. ($MRSN) and 10% Owner in GENOCEA BIOSCIENCES, INC. ($GNCA) and 10% Owner in Roka BioScience, Inc. ($ROKA) and Director in Cloudflare, Inc. ($NET) and 10% Owner in Ra Pharmaceuticals, Inc. ($RARX) and 10% Owner in TESARO, Inc. ($TSRO) and 10% Owner in Regulus Therapeutics Inc. ($RGLS) and 10% Owner in Sprout Social, Inc. ($SPT) and 10% Owner in Mirna Therapeutics, Inc. ($MIRN) and 10% Owner in Cerecor Inc. ($CERC) and 10% Owner in Trevi Therapeutics, Inc. ($TRVI) and 10% Owner in Epizyme, Inc. ($EPZM) and 10% Owner in Adaptimmune Therapeutics PLC ($ADAP) and 10% Owner in Metacrine, Inc. ($MTCR) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and 10% Owner in Inozyme Pharma, Inc. ($INZY) and 10% Owner in Elastic N.V. ($ESTC) and 10% Owner in Eargo, Inc. ($EAR) and 10% Owner in Akouos, Inc. ($AKUS) and 10% Owner in Surface Oncology, Inc. ($SURF) and Director in Bloom Energy Corp ($BE) and 10% Owner in Mirum Pharmaceuticals, Inc. ($MIRM) and 10% Owner in Nkarta, Inc. ($NKTX).
Latest Insider Trading Transactions of SCOTT D SANDELL
Sentiment: All, AKAO, ADAP, AKUS, APPN, ARDM, ABIO, ARDX, AVEO, BE, CRCM, CASC, CBIO, CERC, NET, DDUP, EAR, ESTC, EPZM, GNCA, GLYC, HPTX, INHX, INWK, INZY, IOMI, ILIU, LIQDA, MRKR, MRSN, MTCR, MIRM, MULE, MYOG, NKTX, PRTK, PHRM, RARX, RGLS, RYTM, ROKA, SPT, SUPN, SURF, SYBX, TSRO, TCON, TRVI, VTAE, VG, ZHNE
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 14 2020 | MRSN | Mersana Therapeuti ... | SANDELL SCOTT D | 10% Owner | Sell | S | 8.98 | 1,650 | 14,812 | 0 | 1.7 K to 0 (-100.00 %) |
Apr 13 2020 | MRSN | Mersana Therapeuti ... | SANDELL SCOTT D | 10% Owner | Sell | S | 8.50 | 20,914 | 177,775 | 0 | 20.9 K to 0 (-100.00 %) |
Apr 13 2020 | MRSN | Mersana Therapeuti ... | SANDELL SCOTT D | 10% Owner | Buy | J | 0.00 | 685 | 0 | 1,650 | 965 to 1.7 K (+70.98 %) |
Apr 13 2020 | MRSN | Mersana Therapeuti ... | SANDELL SCOTT D | 10% Owner | Buy | J | 0.00 | 8,783 | 0 | 20,914 | 12.1 K to 20.9 K (+72.40 %) |
Apr 13 2020 | MRSN | Mersana Therapeuti ... | SANDELL SCOTT D | 10% Owner | Buy | J | 0.00 | 965 | 0 | 965 | 0 to 965 |
Apr 13 2020 | MRSN | Mersana Therapeuti ... | SANDELL SCOTT D | 10% Owner | Buy | J | 0.00 | 274 | 0 | 274 | 0 to 274 |
Apr 13 2020 | MRSN | Mersana Therapeuti ... | SANDELL SCOTT D | 10% Owner | Buy | J | 0.00 | 274 | 0 | 274 | 0 to 274 |
Apr 13 2020 | MRSN | Mersana Therapeuti ... | SANDELL SCOTT D | 10% Owner | Buy | J | 0.00 | 12,054 | 0 | 12,131 | 77 to 12.1 K (+15,654.55 %) |
Apr 13 2020 | MRSN | Mersana Therapeuti ... | SANDELL SCOTT D | 10% Owner | Buy | J | 0.00 | 77 | 0 | 77 | 0 to 77 |
Apr 13 2020 | MRSN | Mersana Therapeuti ... | SANDELL SCOTT D | 10% Owner | Sell | J | 0.00 | 20,000 | 0 | 0 | 20 K to 0 (-100.00 %) |
Apr 13 2020 | MRSN | Mersana Therapeuti ... | SANDELL SCOTT D | 10% Owner | Buy | J | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
Apr 13 2020 | MRSN | Mersana Therapeuti ... | SANDELL SCOTT D | 10% Owner | Sell | J | 0.00 | 40,000 | 0 | 0 | 40 K to 0 (-100.00 %) |
Apr 13 2020 | MRSN | Mersana Therapeuti ... | SANDELL SCOTT D | 10% Owner | Buy | J | 0.00 | 40,000 | 0 | 40,000 | 0 to 40 K |
Apr 13 2020 | MRSN | Mersana Therapeuti ... | SANDELL SCOTT D | 10% Owner | Sell | J | 0.00 | 4,000,000 | 0 | 7,959,520 | 12 M to 8 M (-33.45 %) |
Apr 13 2020 | TRVI | Trevi Therapeutics ... | SANDELL SCOTT D | 10% Owner | Option Exercise | X | 0.00 | 1,500,000 | 1,500 | 0 | |
Apr 13 2020 | TRVI | Trevi Therapeutics ... | SANDELL SCOTT D | 10% Owner | Sell | S | 2.66 | 564 | 1,500 | 5,937,998 | 5.9 M to 5.9 M (-0.01 %) |
Apr 13 2020 | TRVI | Trevi Therapeutics ... | SANDELL SCOTT D | 10% Owner | Buy | X | 0.00 | 1,500,000 | 1,500 | 5,938,562 | 4.4 M to 5.9 M (+33.79 %) |
Jan 28 2020 | ADAP | Adaptimmune Therap ... | SANDELL SCOTT D | 10% Owner | Buy | P | 0.67 | 7,500,000 | 5,000,250 | 19,500,000 | 12 M to 19.5 M (+62.50 %) |
Dec 26 2019 | RGLS | Regulus Therapeuti ... | SANDELL SCOTT D | 10% Owner | Option Exercise | P | 0.00 | 900,900 | 0 | 900,900 | |
Dec 26 2019 | RGLS | Regulus Therapeuti ... | SANDELL SCOTT D | 10% Owner | Option Exercise | P | 0.67 | 9,009,000 | 5,999,994 | 9,009,000 | |
Dec 09 2019 | ARDX | ARDELYX, INC. | SANDELL SCOTT D | 10% Owner | Grant | A | 6.25 | 400,000 | 2,500,000 | 3,482,186 | 3.1 M to 3.5 M (+12.98 %) |
Dec 09 2019 | ARDX | ARDELYX, INC. | SANDELL SCOTT D | 10% Owner | Grant | A | 6.25 | 400,000 | 2,500,000 | 9,569,210 | 9.2 M to 9.6 M (+4.36 %) |
Sep 18 2019 | NET | Cloudflare, Inc. | SANDELL SCOTT D | Director | Option Exercise | C | 0.00 | 42,463,920 | 0 | 48,588,474 | |
Sep 18 2019 | NET | Cloudflare, Inc. | SANDELL SCOTT D | Director | Option Exercise | C | 0.00 | 4,059,376 | 0 | 0 | |
Sep 18 2019 | NET | Cloudflare, Inc. | SANDELL SCOTT D | Director | Option Exercise | C | 0.00 | 7,183,310 | 0 | 0 | |
Sep 18 2019 | NET | Cloudflare, Inc. | SANDELL SCOTT D | Director | Option Exercise | C | 0.00 | 35,280,610 | 0 | 0 | |
Sep 18 2019 | NET | Cloudflare, Inc. | SANDELL SCOTT D | Director | Buy | C | 0.00 | 4,059,376 | 0 | 4,059,376 | 0 to 4.1 M |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | SANDELL SCOTT D | 10% Owner | Option Exercise | C | 0.00 | 29,889,945 | 0 | 0 | |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | SANDELL SCOTT D | 10% Owner | Buy | P | 15.00 | 450,000 | 6,750,000 | 4,186,243 | 3.7 M to 4.2 M (+12.04 %) |
Jul 24 2019 | MIRM | Mirum Pharmaceutic ... | SANDELL SCOTT D | 10% Owner | Buy | C | 0.00 | 3,736,243 | 0 | 3,736,243 | 0 to 3.7 M |
Jun 25 2019 | GNCA | GENOCEA BIOSCIENCE ... | SANDELL SCOTT D | 10% Owner | Buy | P | 3.50 | 2,857,142 | 9,999,997 | 7,225,676 | 4.4 M to 7.2 M (+65.40 %) |
Jun 25 2019 | GNCA | GENOCEA BIOSCIENCE ... | SANDELL SCOTT D | 10% Owner | Buy | P | 3.50 | 2,857,142 | 9,999,997 | 7,225,676 | 4.4 M to 7.2 M (+65.40 %) |
May 17 2019 | BE | Bloom Energy Corp | SANDELL SCOTT D | Director | Grant | A | 0.00 | 12,734 | 0 | 12,734 | 0 to 12.7 K |
May 13 2019 | TRVI | Trevi Therapeutics ... | SANDELL SCOTT D | 10% Owner | Option Exercise | C | 0.00 | 17,099,315 | 0 | 0 | |
May 13 2019 | TRVI | Trevi Therapeutics ... | SANDELL SCOTT D | 10% Owner | Buy | P | 10.00 | 1,500,000 | 15,000,000 | 4,438,562 | 2.9 M to 4.4 M (+51.05 %) |
May 13 2019 | TRVI | Trevi Therapeutics ... | SANDELL SCOTT D | 10% Owner | Buy | P | 10.00 | 1,000,000 | 10,000,000 | 2,938,562 | 1.9 M to 2.9 M (+51.58 %) |
May 13 2019 | TRVI | Trevi Therapeutics ... | SANDELL SCOTT D | 10% Owner | Buy | C | 0.00 | 1,938,562 | 0 | 1,938,562 | 0 to 1.9 M |
May 09 2019 | RGLS | Regulus Therapeuti ... | SANDELL SCOTT D | 10% Owner | Option Exercise | P | 0.00 | 256,700 | 0 | 256,700 | |
May 09 2019 | RGLS | Regulus Therapeuti ... | SANDELL SCOTT D | 10% Owner | Option Exercise | P | 1.08 | 3,703,704 | 4,000,000 | 3,703,704 | |
May 09 2019 | RGLS | Regulus Therapeuti ... | SANDELL SCOTT D | 10% Owner | Buy | P | 1.08 | 1,136,704 | 1,227,640 | 2,052,454 | 915.8 K to 2.1 M (+124.13 %) |
Apr 08 2019 | AVEO | AVEO PHARMACEUTICA ... | SANDELL SCOTT D | 10% Owner | Option Exercise | P | 1.25 | 4,347,827 | 5,434,784 | 4,347,827 | |
Apr 08 2019 | AVEO | AVEO PHARMACEUTICA ... | SANDELL SCOTT D | 10% Owner | Buy | P | 1.14 | 4,347,827 | 4,956,523 | 25,243,865 | 20.9 M to 25.2 M (+20.81 %) |
Feb 19 2019 | GNCA | GENOCEA BIOSCIENCE ... | SANDELL SCOTT D | 10% Owner | Option Exercise | P | 0.57 | 2,487,067 | 1,406,685 | 2,487,067 | |
Feb 19 2019 | GNCA | GENOCEA BIOSCIENCE ... | SANDELL SCOTT D | 10% Owner | Buy | P | 0.47 | 9,948,269 | 4,688,619 | 34,948,269 | 25 M to 34.9 M (+39.79 %) |
Jan 22 2019 | TSRO | TESARO, Inc. | SANDELL SCOTT D | 10% Owner | Sell | U | 75.00 | 739,517 | 55,463,775 | 0 | 739.5 K to 0 (-100.00 %) |
Jan 22 2019 | TSRO | TESARO, Inc. | SANDELL SCOTT D | 10% Owner | Sell | U | 75.00 | 9,681,038 | 726,077,850 | 0 | 9.7 M to 0 (-100.00 %) |
Dec 21 2018 | AVEO | AVEO PHARMACEUTICA ... | SANDELL SCOTT D | 10% Owner | Buy | P | 1.49 | 300,000 | 448,380 | 20,896,038 | 20.6 M to 20.9 M (+1.46 %) |
Dec 21 2018 | AVEO | AVEO PHARMACEUTICA ... | SANDELL SCOTT D | 10% Owner | Buy | P | 1.63 | 200,000 | 326,060 | 20,596,038 | 20.4 M to 20.6 M (+0.98 %) |
Dec 12 2018 | AVEO | AVEO PHARMACEUTICA ... | SANDELL SCOTT D | 10% Owner | Buy | P | 1.98 | 61,200 | 121,084 | 20,396,038 | 20.3 M to 20.4 M (+0.30 %) |
Dec 10 2018 | AVEO | AVEO PHARMACEUTICA ... | SANDELL SCOTT D | 10% Owner | Buy | P | 1.98 | 26,000 | 51,576 | 20,334,838 | 20.3 M to 20.3 M (+0.13 %) |
Dec 10 2018 | AVEO | AVEO PHARMACEUTICA ... | SANDELL SCOTT D | 10% Owner | Buy | P | 1.98 | 117,100 | 232,362 | 20,308,838 | 20.2 M to 20.3 M (+0.58 %) |
Dec 10 2018 | AVEO | AVEO PHARMACEUTICA ... | SANDELL SCOTT D | 10% Owner | Buy | P | 1.99 | 27,300 | 54,414 | 20,191,738 | 20.2 M to 20.2 M (+0.14 %) |
Nov 30 2018 | AVEO | AVEO PHARMACEUTICA ... | SANDELL SCOTT D | 10% Owner | Buy | P | 1.98 | 71,900 | 142,067 | 20,164,438 | 20.1 M to 20.2 M (+0.36 %) |
Nov 30 2018 | AVEO | AVEO PHARMACEUTICA ... | SANDELL SCOTT D | 10% Owner | Buy | P | 1.99 | 24,500 | 48,824 | 20,092,538 | 20.1 M to 20.1 M (+0.12 %) |
Nov 21 2018 | AVEO | AVEO PHARMACEUTICA ... | SANDELL SCOTT D | 10% Owner | Buy | P | 1.98 | 170,000 | 336,107 | 20,068,038 | 19.9 M to 20.1 M (+0.85 %) |
Nov 21 2018 | AVEO | AVEO PHARMACEUTICA ... | SANDELL SCOTT D | 10% Owner | Buy | P | 1.98 | 170,000 | 336,107 | 20,068,038 | 19.9 M to 20.1 M (+0.85 %) |
Nov 19 2018 | AVEO | AVEO PHARMACEUTICA ... | SANDELL SCOTT D | 10% Owner | Buy | P | 1.88 | 510,000 | 956,658 | 19,898,038 | 19.4 M to 19.9 M (+2.63 %) |
Nov 19 2018 | AVEO | AVEO PHARMACEUTICA ... | SANDELL SCOTT D | 10% Owner | Buy | P | 1.86 | 350,000 | 649,355 | 19,388,038 | 19 M to 19.4 M (+1.84 %) |
Nov 19 2018 | AVEO | AVEO PHARMACEUTICA ... | SANDELL SCOTT D | 10% Owner | Buy | P | 1.86 | 340,000 | 631,958 | 19,038,038 | 18.7 M to 19 M (+1.82 %) |
Nov 13 2018 | ARDX | ARDELYX, INC. | SANDELL SCOTT D | 10% Owner | Sell | S | 2.98 | 592 | 1,767 | 0 | 592 to 0 (-100.00 %) |
Oct 10 2018 | ESTC | Elastic N.V. | SANDELL SCOTT D | 10% Owner | Option Exercise | C | 0.00 | 1,528,117 | 0 | 0 | |
Oct 10 2018 | ESTC | Elastic N.V. | SANDELL SCOTT D | 10% Owner | Option Exercise | C | 0.00 | 4,155,995 | 0 | 0 | |
Oct 10 2018 | ESTC | Elastic N.V. | SANDELL SCOTT D | 10% Owner | Buy | C | 0.00 | 1,528,117 | 0 | 1,528,117 | 0 to 1.5 M |
Oct 10 2018 | ESTC | Elastic N.V. | SANDELL SCOTT D | 10% Owner | Buy | C | 0.00 | 4,155,995 | 0 | 4,155,995 | 0 to 4.2 M |
Sep 10 2018 | ADAP | Adaptimmune Therap ... | SANDELL SCOTT D | 10% Owner | Buy | P | 1.67 | 12,000,000 | 20,000,400 | 12,000,000 | 0 to 12 M |
Sep 10 2018 | ADAP | Adaptimmune Therap ... | SANDELL SCOTT D | 10% Owner | Buy | P | 1.67 | 3,000,000 | 5,000,100 | 82,978,668 | 80 M to 83 M (+3.75 %) |
Aug 22 2018 | AVEO | AVEO PHARMACEUTICA ... | SANDELL SCOTT D | 10% Owner | Buy | P | 2.26 | 663,716 | 1,499,998 | 18,698,038 | 18 M to 18.7 M (+3.68 %) |
Aug 01 2018 | LQDA | Liquidia Technolog ... | SANDELL SCOTT D | 10% Owner | Option Exercise | J | 0.01 | 40,702 | 407 | 40,702 | |
Aug 01 2018 | LQDA | Liquidia Technolog ... | SANDELL SCOTT D | 10% Owner | Option Exercise | J | 0.01 | 684,911 | 6,849 | 0 | |
Aug 01 2018 | LQDA | Liquidia Technolog ... | SANDELL SCOTT D | 10% Owner | Option Exercise | C | 0.00 | 16,502,833 | 0 | 0 | |
Aug 01 2018 | LQDA | Liquidia Technolog ... | SANDELL SCOTT D | 10% Owner | Option Exercise | C | 0.00 | 3,337,206 | 0 | 0 | |
Aug 01 2018 | LQDA | Liquidia Technolog ... | SANDELL SCOTT D | 10% Owner | Option Exercise | C | 0.00 | 3,645,307 | 0 | 0 | |
Aug 01 2018 | LQDA | Liquidia Technolog ... | SANDELL SCOTT D | 10% Owner | Buy | P | 11.00 | 545,455 | 6,000,005 | 2,484,870 | 1.9 M to 2.5 M (+28.12 %) |
Aug 01 2018 | LQDA | Liquidia Technolog ... | SANDELL SCOTT D | 10% Owner | Buy | C | 0.00 | 980,715 | 0 | 1,939,415 | 958.7 K to 1.9 M (+102.30 %) |
Aug 01 2018 | LQDA | Liquidia Technolog ... | SANDELL SCOTT D | 10% Owner | Buy | C | 0.00 | 432,033 | 0 | 958,700 | 526.7 K to 958.7 K (+82.03 %) |
Aug 01 2018 | LQDA | Liquidia Technolog ... | SANDELL SCOTT D | 10% Owner | Buy | C | 0.00 | 515,547 | 0 | 526,667 | 11.1 K to 526.7 K (+4,636.21 %) |
Jul 31 2018 | BE | Bloom Energy Corp | SANDELL SCOTT D | Director | Option Exercise | C | 0.00 | 346,239 | 0 | 7,729,641 | |
Jul 31 2018 | BE | Bloom Energy Corp | SANDELL SCOTT D | Director | Option Exercise | C | 0.00 | 346,239 | 0 | 0 | |
Jul 31 2018 | BE | Bloom Energy Corp | SANDELL SCOTT D | Director | Option Exercise | C | 0.00 | 650,631 | 0 | 7,383,402 | |
Jul 31 2018 | BE | Bloom Energy Corp | SANDELL SCOTT D | Director | Option Exercise | C | 0.00 | 650,631 | 0 | 0 | |
Jul 31 2018 | BE | Bloom Energy Corp | SANDELL SCOTT D | Director | Option Exercise | C | 0.00 | 125,989 | 0 | 6,732,771 | |
Jul 31 2018 | BE | Bloom Energy Corp | SANDELL SCOTT D | Director | Option Exercise | C | 0.00 | 125,989 | 0 | 0 | |
Jul 31 2018 | BE | Bloom Energy Corp | SANDELL SCOTT D | Director | Option Exercise | C | 0.00 | 395,815 | 0 | 6,606,782 | |
Jul 31 2018 | BE | Bloom Energy Corp | SANDELL SCOTT D | Director | Option Exercise | C | 0.00 | 395,815 | 0 | 0 | |
Jul 31 2018 | BE | Bloom Energy Corp | SANDELL SCOTT D | Director | Option Exercise | C | 0.00 | 620,155 | 0 | 6,210,967 | |
Jul 31 2018 | BE | Bloom Energy Corp | SANDELL SCOTT D | Director | Option Exercise | C | 0.00 | 620,155 | 0 | 0 | |
Jul 31 2018 | BE | Bloom Energy Corp | SANDELL SCOTT D | Director | Option Exercise | C | 0.00 | 1,062,944 | 0 | 5,590,812 | |
Jul 31 2018 | BE | Bloom Energy Corp | SANDELL SCOTT D | Director | Option Exercise | C | 0.00 | 1,062,944 | 0 | 0 | |
Jul 31 2018 | BE | Bloom Energy Corp | SANDELL SCOTT D | Director | Option Exercise | C | 0.00 | 4,527,868 | 0 | 4,527,868 | |
Jul 31 2018 | BE | Bloom Energy Corp | SANDELL SCOTT D | Director | Option Exercise | C | 0.00 | 4,527,868 | 0 | 0 | |
Jul 31 2018 | BE | Bloom Energy Corp | SANDELL SCOTT D | Director | Buy | P | 15.00 | 1,333,333 | 19,999,995 | 1,333,333 | 0 to 1.3 M |
Jul 20 2018 | AVEO | AVEO PHARMACEUTICA ... | SANDELL SCOTT D | 10% Owner | Buy | P | 2.00 | 50,600 | 101,165 | 18,034,322 | 18 M to 18 M (+0.28 %) |
Jul 20 2018 | AVEO | AVEO PHARMACEUTICA ... | SANDELL SCOTT D | 10% Owner | Buy | P | 1.95 | 200,000 | 390,580 | 17,983,722 | 17.8 M to 18 M (+1.12 %) |
Jun 28 2018 | AVEO | AVEO PHARMACEUTICA ... | SANDELL SCOTT D | 10% Owner | Buy | P | 2.10 | 187,130 | 392,692 | 17,783,722 | 17.6 M to 17.8 M (+1.06 %) |
Jun 28 2018 | AVEO | AVEO PHARMACEUTICA ... | SANDELL SCOTT D | 10% Owner | Buy | P | 2.15 | 5,295 | 11,384 | 17,596,592 | 17.6 M to 17.6 M (+0.03 %) |
May 30 2018 | AVEO | AVEO PHARMACEUTICA ... | SANDELL SCOTT D | 10% Owner | Buy | P | 2.15 | 275 | 591 | 17,591,297 | 17.6 M to 17.6 M (0.00 %) |
May 30 2018 | ARDX | ARDELYX, INC. | SANDELL SCOTT D | 10% Owner | Grant | A | 4.00 | 416,667 | 1,666,668 | 3,082,186 | 2.7 M to 3.1 M (+15.63 %) |
May 30 2018 | ARDX | ARDELYX, INC. | SANDELL SCOTT D | 10% Owner | Grant | A | 4.00 | 416,666 | 1,666,664 | 3,082,186 | 2.7 M to 3.1 M (+15.63 %) |
May 30 2018 | ARDX | ARDELYX, INC. | SANDELL SCOTT D | 10% Owner | Grant | A | 4.00 | 416,667 | 1,666,668 | 9,169,210 | 8.8 M to 9.2 M (+4.76 %) |
May 21 2018 | AVEO | AVEO PHARMACEUTICA ... | SANDELL SCOTT D | 10% Owner | Buy | P | 2.14 | 32,200 | 69,059 | 17,591,022 | 17.6 M to 17.6 M (+0.18 %) |
May 21 2018 | AVEO | AVEO PHARMACEUTICA ... | SANDELL SCOTT D | 10% Owner | Buy | P | 2.14 | 20,100 | 42,928 | 17,558,822 | 17.5 M to 17.6 M (+0.11 %) |
May 21 2018 | AVEO | AVEO PHARMACEUTICA ... | SANDELL SCOTT D | 10% Owner | Buy | P | 2.13 | 184,179 | 391,436 | 17,538,722 | 17.4 M to 17.5 M (+1.06 %) |
May 11 2018 | GLYC | GLYCOMIMETICS INC | SANDELL SCOTT D | 10% Owner | Option Exercise | X | 0.33 | 298,406 | 98,474 | 0 | |
May 11 2018 | GLYC | GLYCOMIMETICS INC | SANDELL SCOTT D | 10% Owner | Option Exercise | X | 0.33 | 216,046 | 71,295 | 0 | |
May 11 2018 | GLYC | GLYCOMIMETICS INC | SANDELL SCOTT D | 10% Owner | Sell | S | 17.81 | 5,533 | 98,543 | 4,995,664 | 5 M to 5 M (-0.11 %) |
May 11 2018 | GLYC | GLYCOMIMETICS INC | SANDELL SCOTT D | 10% Owner | Buy | X | 0.33 | 298,406 | 98,474 | 5,001,197 | 4.7 M to 5 M (+6.35 %) |
May 11 2018 | GLYC | GLYCOMIMETICS INC | SANDELL SCOTT D | 10% Owner | Sell | S | 17.81 | 4,006 | 71,347 | 4,702,791 | 4.7 M to 4.7 M (-0.09 %) |
May 11 2018 | GLYC | GLYCOMIMETICS INC | SANDELL SCOTT D | 10% Owner | Buy | X | 0.33 | 216,046 | 71,295 | 4,706,797 | 4.5 M to 4.7 M (+4.81 %) |
May 10 2018 | AVEO | AVEO PHARMACEUTICA ... | SANDELL SCOTT D | 10% Owner | Buy | P | 2.13 | 70,873 | 151,250 | 17,354,543 | 17.3 M to 17.4 M (+0.41 %) |
May 09 2018 | MULE | MULESOFT, INC | SANDELL SCOTT D | 10% Owner | Option Exercise | C | 0.00 | 858,978 | 0 | 0 | |
May 09 2018 | MULE | MULESOFT, INC | SANDELL SCOTT D | 10% Owner | Option Exercise | C | 0.00 | 2,576,939 | 0 | 0 | |
May 09 2018 | MULE | MULESOFT, INC | SANDELL SCOTT D | 10% Owner | Option Exercise | C | 0.00 | 12,679,970 | 0 | 0 | |
May 09 2018 | MULE | MULESOFT, INC | SANDELL SCOTT D | 10% Owner | Sell | U | 0.00 | 858,978 | 0 | 0 | 859 K to 0 (-100.00 %) |
May 09 2018 | MULE | MULESOFT, INC | SANDELL SCOTT D | 10% Owner | Buy | C | 0.00 | 858,978 | 0 | 858,978 | 0 to 859 K |
May 09 2018 | MULE | MULESOFT, INC | SANDELL SCOTT D | 10% Owner | Sell | U | 0.00 | 2,576,939 | 0 | 0 | 2.6 M to 0 (-100.00 %) |
May 09 2018 | MULE | MULESOFT, INC | SANDELL SCOTT D | 10% Owner | Buy | C | 0.00 | 2,576,939 | 0 | 2,576,939 | 0 to 2.6 M |
May 09 2018 | MULE | MULESOFT, INC | SANDELL SCOTT D | 10% Owner | Sell | U | 0.00 | 12,679,970 | 0 | 0 | 12.7 M to 0 (-100.00 %) |
May 09 2018 | MULE | MULESOFT, INC | SANDELL SCOTT D | 10% Owner | Buy | C | 0.00 | 12,679,970 | 0 | 12,679,970 | 0 to 12.7 M |
Apr 23 2018 | SURF | Surface Oncology, ... | SANDELL SCOTT D | 10% Owner | Option Exercise | C | 0.00 | 6,995,000 | 0 | 0 | |
Apr 23 2018 | SURF | Surface Oncology, ... | SANDELL SCOTT D | 10% Owner | Buy | P | 15.00 | 133,333 | 1,999,995 | 3,312,877 | 3.2 M to 3.3 M (+4.19 %) |
Apr 23 2018 | SURF | Surface Oncology, ... | SANDELL SCOTT D | 10% Owner | Buy | C | 0.00 | 3,179,544 | 0 | 3,179,544 | 0 to 3.2 M |
Apr 23 2018 | SURF | Surface Oncology, ... | SANDELL SCOTT D | 10% Owner | Option Exercise | C | 0.00 | 6,995,000 | 0 | 0 | |
Apr 23 2018 | SURF | Surface Oncology, ... | SANDELL SCOTT D | 10% Owner | Buy | P | 15.00 | 133,333 | 1,999,995 | 3,312,877 | 3.2 M to 3.3 M (+4.19 %) |
Apr 23 2018 | SURF | Surface Oncology, ... | SANDELL SCOTT D | 10% Owner | Buy | C | 0.00 | 3,179,544 | 0 | 3,179,544 | 0 to 3.2 M |
Apr 10 2018 | AVEO | AVEO PHARMACEUTICA ... | SANDELL SCOTT D | 10% Owner | Buy | P | 2.46 | 203,200 | 499,994 | 17,283,670 | 17.1 M to 17.3 M (+1.19 %) |
Apr 10 2018 | AVEO | AVEO PHARMACEUTICA ... | SANDELL SCOTT D | 10% Owner | Buy | P | 2.43 | 32,100 | 78,099 | 17,080,470 | 17 M to 17.1 M (+0.19 %) |
Apr 10 2018 | AVEO | AVEO PHARMACEUTICA ... | SANDELL SCOTT D | 10% Owner | Buy | P | 2.24 | 685,676 | 1,536,943 | 17,048,370 | 16.4 M to 17 M (+4.19 %) |
Mar 28 2018 | ADAP | Adaptimmune Therap ... | SANDELL SCOTT D | 10% Owner | Buy | P | 1.92 | 6,000,000 | 11,500,200 | 79,978,672 | 74 M to 80 M (+8.11 %) |
Mar 28 2018 | ADAP | Adaptimmune Therap ... | SANDELL SCOTT D | 10% Owner | Buy | P | 1.90 | 571,164 | 1,087,553 | 73,978,672 | 73.4 M to 74 M (+0.78 %) |
Mar 27 2018 | TCON | Tracon Pharmaceuti ... | SANDELL SCOTT D | 10% Owner | Option Exercise | P | 2.70 | 707,964 | 1,911,503 | 707,964 | |
Mar 27 2018 | TCON | Tracon Pharmaceuti ... | SANDELL SCOTT D | 10% Owner | Buy | P | 2.70 | 707,964 | 1,911,503 | 3,466,003 | 2.8 M to 3.5 M (+25.67 %) |
Mar 23 2018 | ADAP | Adaptimmune Therap ... | SANDELL SCOTT D | 10% Owner | Buy | P | 1.95 | 294,090 | 572,358 | 73,407,508 | 73.1 M to 73.4 M (+0.40 %) |
Mar 23 2018 | ADAP | Adaptimmune Therap ... | SANDELL SCOTT D | 10% Owner | Buy | P | 1.90 | 869,574 | 1,655,669 | 73,113,418 | 72.2 M to 73.1 M (+1.20 %) |
Mar 23 2018 | ADAP | Adaptimmune Therap ... | SANDELL SCOTT D | 10% Owner | Buy | P | 1.81 | 104,844 | 189,820 | 72,243,844 | 72.1 M to 72.2 M (+0.15 %) |
Mar 13 2018 | CASC | Cascadian Therapeu ... | SANDELL SCOTT D | 10% Owner | Sell | U | 0.00 | 10,882,574 | 0 | 0 | 10.9 M to 0 (-100.00 %) |
Mar 06 2018 | TSRO | TESARO, Inc. | SANDELL SCOTT D | 10% Owner | Buy | P | 59.82 | 3,159 | 188,957 | 739,516 | 736.4 K to 739.5 K (+0.43 %) |
Mar 06 2018 | TSRO | TESARO, Inc. | SANDELL SCOTT D | 10% Owner | Buy | P | 59.76 | 4,311 | 257,643 | 736,357 | 732 K to 736.4 K (+0.59 %) |
Mar 06 2018 | TSRO | TESARO, Inc. | SANDELL SCOTT D | 10% Owner | Buy | P | 59.15 | 400 | 23,658 | 732,046 | 731.6 K to 732 K (+0.05 %) |
Mar 06 2018 | TSRO | TESARO, Inc. | SANDELL SCOTT D | 10% Owner | Buy | P | 58.28 | 7,557 | 440,433 | 731,646 | 724.1 K to 731.6 K (+1.04 %) |
Mar 06 2018 | TSRO | TESARO, Inc. | SANDELL SCOTT D | 10% Owner | Buy | P | 57.34 | 4,465 | 256,043 | 724,089 | 719.6 K to 724.1 K (+0.62 %) |
Mar 06 2018 | TSRO | TESARO, Inc. | SANDELL SCOTT D | 10% Owner | Buy | P | 56.66 | 1,020 | 57,794 | 719,624 | 718.6 K to 719.6 K (+0.14 %) |
Mar 06 2018 | TSRO | TESARO, Inc. | SANDELL SCOTT D | 10% Owner | Buy | P | 55.01 | 1,600 | 88,015 | 718,604 | 717 K to 718.6 K (+0.22 %) |
Mar 06 2018 | TSRO | TESARO, Inc. | SANDELL SCOTT D | 10% Owner | Buy | P | 54.32 | 6,575 | 357,165 | 717,004 | 710.4 K to 717 K (+0.93 %) |
Mar 06 2018 | TSRO | TESARO, Inc. | SANDELL SCOTT D | 10% Owner | Buy | P | 59.82 | 12,634 | 755,708 | 9,681,129 | 9.7 M to 9.7 M (+0.13 %) |
Mar 06 2018 | TSRO | TESARO, Inc. | SANDELL SCOTT D | 10% Owner | Buy | P | 59.76 | 17,248 | 1,030,813 | 9,668,495 | 9.7 M to 9.7 M (+0.18 %) |
Mar 06 2018 | TSRO | TESARO, Inc. | SANDELL SCOTT D | 10% Owner | Buy | P | 59.15 | 1,600 | 94,634 | 9,651,247 | 9.6 M to 9.7 M (+0.02 %) |
Mar 06 2018 | TSRO | TESARO, Inc. | SANDELL SCOTT D | 10% Owner | Buy | P | 58.28 | 30,321 | 1,767,153 | 9,649,647 | 9.6 M to 9.6 M (+0.32 %) |
Mar 06 2018 | TSRO | TESARO, Inc. | SANDELL SCOTT D | 10% Owner | Buy | P | 57.34 | 17,859 | 1,024,114 | 9,619,326 | 9.6 M to 9.6 M (+0.19 %) |
Mar 06 2018 | TSRO | TESARO, Inc. | SANDELL SCOTT D | 10% Owner | Buy | P | 56.66 | 4,080 | 231,174 | 9,601,467 | 9.6 M to 9.6 M (+0.04 %) |
Mar 06 2018 | TSRO | TESARO, Inc. | SANDELL SCOTT D | 10% Owner | Buy | P | 55.01 | 6,399 | 352,005 | 9,597,387 | 9.6 M to 9.6 M (+0.07 %) |